Localised gastrointestinal diffuse large B cell lymphomas; Does surgical approach still exist?

[1] Psyrri1 A, Papageorgiou S & Economopoulos T; Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management Annals of Oncology 19: 1992-1999, 200810.1093/annonc/mdn525Search in Google Scholar

[2] Ferrucci PF, Zucca E. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years? Br J Haematol 136: 521-538, 200710.1111/j.1365-2141.2006.06444.xSearch in Google Scholar

[3] Cogliatti SB, Schmid U, Schumacher U et al; . Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology 1991; 101: 1159-1170.10.1016/0016-5085(91)90063-QSearch in Google Scholar

[4] National Comprehensive Cancer Network. http:// www.nccn.org/gls.PDF. Accessed January 10th, 2014.Search in Google Scholar

[5] Kim S, Kang H, Kim J, et al; Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. blood 117: 1958-1965,201110.1182/blood-2010-06-28848021148334Search in Google Scholar

[6] Daum S, Ullrich R, Heise W, et al. Intestinal non- Hodgkin’s lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin’s Lymphoma. J Clin Oncol.;21(14):2740-2746.200310.1200/JCO.2003.06.02612860953Search in Google Scholar

[7] Lee J, Kim WS, Kim K, et al. Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment. Leuk Lymphoma. ;45(2):339-344,2004Search in Google Scholar

[8] Tanaka T, Shimada K, Yamamoto K, et al; Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan. Ann Hematol. Mar;91(3):383-90,201210.1007/s00277-011-1306-021822617Search in Google Scholar

[9] Li X, Shen W, Cao J et al; Treatment of gastrointestinal diffuse large B cell lymphoma in China: a 10-year retrospective study of 114 cases. Ann Hematol. 91:1721-9,201210.1007/s00277-012-1507-122733613Search in Google Scholar

[10] Brands F, Mönig SP, Raab M: Treatment and prognosis of gastric lymphoma. Eur J Surg 163:803-813, 1997Search in Google Scholar

[11] Fischbach W, Dragosics B, Kolve Gobeler ME, et al: Primary gastric B-cell-lymphoma: Results of a prospective multicenter study. Gastroenterology 119:1191-1202, 200010.1053/gast.2000.1957911054376Search in Google Scholar

[12] Rodríguez-Sanjuán J , García R, Trugeda S, et al; Do current indications for surgery of primary gastric lymphoma exist? Rev Esp Enferm Dig (Madrid) 98. 180-188,200610.4321/S1130-0108200600030000416737417Search in Google Scholar

[13] Koch P, Probst A, Berdel WE, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol. 23(28):7050-7059.200510.1200/JCO.2005.04.03116129843Search in Google Scholar

[14] Sohn BS, Kim SM, Yoon DH,et al; The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma. Ann Hematol. 91:1731-9.2012.10.1007/s00277-012-1512-4Search in Google Scholar

[15] Rohatiner A, d’Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol. 5:397- 400.199410.1093/oxfordjournals.annonc.a058869Search in Google Scholar

[16] Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 47:207-214. 198110.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6Search in Google Scholar

[17] Kaplan EL, Meier P , Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958, 53:457-481.10.1080/01621459.1958.10501452Search in Google Scholar

[18] Ghimire P, Wu G, Zhu L ;Primary gastrointestinal lymphoma World J Gastroenterol; 17: 697-707 201110.3748/wjg.v17.i6.697Search in Google Scholar

[19] Kim SJ, Choi CW, Mun YC, et al,. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL) BMC Cancer 11:321, 201110.1186/1471-2407-11-321Search in Google Scholar

[20] d’Amore F, Brincker H, Gronbaek K, et al; Non- Hodgkin’s lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group. J Clin Oncol 12:1673-1684. 199410.1200/JCO.1994.12.8.1673Search in Google Scholar

[21] Ko YH, Kim CW, Park CS, et al; REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European- American lymphoma. Cancer , 83:806-812. 199810.1002/(SICI)1097-0142(19980815)83:4<806::AID-CNCR26>3.0.CO;2-VSearch in Google Scholar

[22] Nakamura S, Matsumoto T, Iida M, Yao T, Tsuneyoshi M: Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer 97:2462-2473. 200310.1002/cncr.11415Search in Google Scholar

[23] Brands F, Mönig SP, Raab M: Treatment and prognosis of gastric lymphoma. Eur J Surg 163:803-813, 1997Search in Google Scholar

[24] De Jong D, Aleman BM, Taal BG, et al: Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: An international survey. Ann Oncol 10:275-280, 1999.10.1023/A:1008392022152Search in Google Scholar

[25] Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W, Grothaus-Pinke B, Reinartz G, Brockmann J, Temmesfeld A, et al: Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol 19:3861-3873, 200110.1200/JCO.2001.19.18.386111559724Search in Google Scholar

[26] O H D, Choi IS, Kim JH, et al; Management of gastric lymphoma with chemotherapy alone. Leuk Lymphoma. 46:1329-35. 2005.10.1080/1042819050015565216109611Search in Google Scholar

[27] Lee J, Kim WS, Kim K, et al; prospective clinical study of surgical resection followed by CHOP in localized intestinal diffuse large B cell lymphoma. Leuk Res.;31:359-364. 2007.10.1016/j.leukres.2006.06.01816930692Search in Google Scholar

[28] Daum S, Ullrich R, Heise W, et al. Intestinal non- Hodgkin’s lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin’s Lymphoma. J Clin Oncol.;21):2740-2746. 200310.1200/JCO.2003.06.02612860953Search in Google Scholar

[29] Ibrahim EM, Ezzat AA, Raja MA et al. Primary gastric non-Hodgkin’s lymphoma: clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphoma. Ann Oncol1999; 10: 1441-1449.10.1023/A:1008325823967Search in Google Scholar

[30] Nakamura S, Matsumoto T, Iida M, Yao T, Tsuneyoshi M. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer. 2003;97(10):2462-2473.10.1002/cncr.1141512733145Search in Google Scholar

[31] Lee J, Kim WS, Kim K, et al. Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment. Leuk Lymphoma. 2004;45(2):339-344. 10.1080/1042819031000159311115101721Search in Google Scholar